The University of Vermont Cancer Center Clinical Trials Office (CTO) supports ground-breaking cancer research advancements by facilitating collaborative, high-quality clinical and translational research (applying what we've learned in the lab to clinical trials) aimed at enhancing the prevention, detection and treatment of cancer.
The CTO upholds the highest standards of clinical research by ensuring patient safety, regulatory compliance, and data integrity, while enhancing the lives of those at risk for and affected by cancer.
Open Trials
Clinical trials are almost universally the best option a patient has for treating their cancer. The UVM Cancer Center offers clinical trials for patients across a range of cancer types and stages as well as health care delivery studies.
View Enrolling Clinical TrialsClinical Trials News
What’s It Like to Be on a Cancer Clinical Trial? We Asked a Patient.
Our Team
We're spotlighting our clinical trials staff on Instagram in honor of Clinical Trials Awareness Day, May 20.
Meet Edwin Tobin (Glens Falls Hospital) Meet Karen Mcquesten (Central Vermont Medical Center)
Clinical Trial Spotlight
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Clinical Trial: Do you have numbness, tingling, burning or other symptoms in your hands or feet from your recent chemotherapy treatments? You might have nerve damage called “neuropathy.”
CIPN Clinical Trial Details
Clinical Trials Podcast
Our clinical trials administrative director, Christa Varnadoe, DNP, and our associate director for clinical and translational research, Jessica Heath, MD, joined forces for this episode of "Designing Care On-Air" with host Elizabeth Johnson, PhD.
Listen: Health Care without WallsQuestions about joining a clinical trial?
Please call the clinical trials office: (802) 656-4414, extension 2.
Why Clinical Trials Matter
"Clinical trials provide hope for new and more effective treatments."